A novel vaccine adjuvant based on straight polyacrylate potentiates vaccine-induced humoral and cellular immunity in cynomolgus macaques

References

• Reed SG, Orr MT, Fox CB. Key roles of adjuvants in modern vaccines. Nat Med. 2013;19:1597–608. doi:10.1038/nm.3409.
   PubMed Web of Science ®Google Scholar
• Nanishi E, Dowling DJ, Levy O. Toward precision adjuvants: optimizing science and safety. Curr Opin Pediatr. 2020;32:125–38. doi:10.1097/MOP.0000000000000868.
   PubMed Web of Science ®Google Scholar
• Bonam SR, Partidos CD, Halmuthur SKM, Muller S. An overview of novel adjuvants designed for improving vaccine efficacy. Trends Pharmacol Sci. 2017;38:771–93. doi:10.1016/j.tips.2017.06.002.
   PubMed Web of Science ®Google Scholar
• Knudsen NP, Olsen A, Buonsanti C, et al. Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens. Sci Rep. 2016;6:19570. doi:10.1038/srep19570.
   PubMed Web of Science ®Google Scholar
• Regelson W. The biologic activity of polyanions: past history and new perspectives. J Polym Sci. 1979;66:483–538.
   Google Scholar
• MI M. Polyelectrolytes in immunology: fundamentals and perspectives. Turk J Chem. 1996;20:126–38.
   Web of Science ®Google Scholar
• Powell BS, Andrianov AK, Fusco PC. Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes. Clin Exp Vaccine Res. 2015;4:23–45. doi:10.7774/cevr.2015.4.1.23.
   PubMed Web of Science ®Google Scholar
• Garinot M, Piras-Douce F, Probeck P, Chambon V, Varghese K, Liu Y, Luna E, Drake D, Haensler J. A potent novel vaccine adjuvant based on straight polyacrylate. Int J Pharm. 2020;2:100054.
   Google Scholar
• Thompson EA, Lore K. Non-human primates as a model for understanding the mechanism of action of toll-like receptor-based vaccine adjuvants. Curr Opin Immunol. 2017;47:1–7. doi:10.1016/j.coi.2017.06.006.
   PubMed Web of Science ®Google Scholar
• Swanson KA, Rainho-Tomko JN, Williams ZP, et al. A respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domain. Sci Immunol. 2020;5. doi:10.1126/sciimmunol.aba6466
   PubMed Web of Science ®Google Scholar
• Klucker MF, Dalencon F, Probeck P, Haensler J. AF03, an alternative squalene emulsion-based vaccine adjuvant prepared by a phase inversion temperature method. J Pharm Sci. 2012;101:4490–500. doi:10.1002/jps.23311.
   PubMed Web of Science ®Google Scholar
• Graham BS. Immunological goals for respiratory syncytial virus vaccine development. Curr Opin Immunol. 2019;59:57–64. doi:10.1016/j.coi.2019.03.005.
   PubMed Web of Science ®Google Scholar
• McLellan JS, Chen M, Joyce MG, et al. Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science. 2013;342:592–98. doi:10.1126/science.1243283.
   PubMed Web of Science ®Google Scholar
• Geskey JM, Thomas NJ, Brummel GL. Palivizumab: a review of its use in the protection of high risk infants against respiratory syncytial virus (RSV). Biologics. 2007;1:33–43.
   PubMedGoogle Scholar
• Habibi MS, Jozwik A, Makris S, Dunning J, Paras A, DeVincenzo JP, de Haan CA, Wrammert J, Openshaw PJ, Chiu C. Impaired antibody-mediated protection and defective IgA B-cell memory in experimental infection of adults with respiratory syncytial virus. Am J Respir Crit Care Med. 2015;191:1040–49. doi:10.1164/rccm.201412-2256OC.
   PubMed Web of Science ®Google Scholar
• Vissers M, Ahout IM, de Jonge MI, Ferwerda G. Mucosal IgG levels correlate better with respiratory syncytial virus load and inflammation than plasma IgG levels. Clin Vaccine Immunol. 2015;23:243–45. doi:10.1128/CVI.00590-15.
   PubMed Web of Science ®Google Scholar
• Walsh EE, Falsey AR. Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults. J Infect Dis. 2004;190:373–78. doi:10.1086/421524.
   PubMed Web of Science ®Google Scholar
• Akkaya M, Kwak K, Pierce SK. B cell memory: building two walls of protection against pathogens. Nat Rev Immunol. 2020;20:229–38. doi:10.1038/s41577-019-0244-2.
   PubMed Web of Science ®Google Scholar
• Kurosaki T, Kometani K, Ise W. Memory B cells. Nat Rev Immunol. 2015;15:149–59. doi:10.1038/nri3802.
   PubMed Web of Science ®Google Scholar
• Plotkin SA, Orenstein WA, Offit PA, Edwards KM. Plotkin’s Vaccines. Elsevier; 2018. https://www.elsevier.com/books/T/A/9780323357616
   Google Scholar
• Sette A, Rappuoli R. Reverse vaccinology: developing vaccines in the era of genomics. Immunity. 2010;33:530–41. doi:10.1016/j.immuni.2010.09.017.
   PubMed Web of Science ®Google Scholar
• Altindis E, Tefon BE, Yildirim V, Ozcengiz E, Becher D, Hecker M, Özcengiz G. Immunoproteomic analysis of Bordetella pertussis and identification of new immunogenic proteins. Vaccine. 2009;27:542–48. doi:10.1016/j.vaccine.2008.11.020.
   PubMed Web of Science ®Google Scholar
• Dennehy R, McClean S. Immunoproteomics: the key to discovery of new vaccine antigens against bacterial respiratory infections. Curr Protein Pept Sci. 2012;13:807–15. doi:10.2174/138920312804871184.
   PubMed Web of Science ®Google Scholar
• Holtfreter S, Kolata J, Stentzel S, Bauerfeind S, Schmidt F, Sundaramoorthy N, Bröker BM. Omics approaches for the study of adaptive immunity to staphylococcus aureus and the selection of vaccine candidates. Proteomes. 2016;4. doi:10.3390/proteomes4010011
   PubMed Web of Science ®Google Scholar
• Payne LG, Andrianov AK. Protein release from polyphosphazene matrices. Adv Drug Deliv Rev. 1998;31:185–96. doi:10.1016/S0169-409X(97)00122-1.
   PubMed Web of Science ®Google Scholar
• Payne LG, Jenkins SA, Andrianov A, Roberts BE. Water-soluble phosphazene polymers for parenteral and mucosal vaccine delivery. Pharm Biotechnol. 1995;6:473–93.
   PubMedGoogle Scholar
• Cayatte C, Marin A, Rajani GM, Schneider-Ohrum K, Snell Bennett A, Marshall JD, Andrianov AK. PCPP-adjuvanted respiratory syncytial virus (RSV) sF subunit vaccine: self-assembled supramolecular complexes enable enhanced immunogenicity and protection. Mol Pharm. 2017;14:2285–93. doi:10.1021/acs.molpharmaceut.7b00118.
   PubMed Web of Science ®Google Scholar
• Mapletoft JW, Oumouna M, Kovacs-Nolan J, Latimer L, Mutwiri G, Babiuk LA. Intranasal immunization of mice with a formalin-inactivated bovine respiratory syncytial virus vaccine co-formulated with CpG oligodeoxynucleotides and polyphosphazenes results in enhanced protection. J Gen Virol. 2008;89:250–60. doi:10.1099/vir.0.83300-0.
   PubMed Web of Science ®Google Scholar
• Andrianov AK, Marin A, Chen J. Synthesis, properties, and biological activity of poly[di(sodium carboxylatoethylphenoxy)phosphazene]. Biomacromolecules. 2006;7:394–99. doi:10.1021/bm050790a.
   PubMed Web of Science ®Google Scholar
• Dilai M, Piro M, El Harrak M, Fougerolle S, Dehhaoui M, Dikrallah A, Legrand L, Paillot R, Fassi Fihri O. Impact of mixed equine influenza vaccination on correlate of protection in horses. Vaccines (Basel). 2018;6,71. doi:10.3390/vaccines6040071
   Web of Science ®Google Scholar
• Baldrick P. Dose site reactions and related findings after vaccine administration in safety studies. J Appl Toxicol. 2016;36:980–90. doi:10.1002/jat.3314.
   PubMed Web of Science ®Google Scholar
• Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol. 2010;17:1055–65. doi:10.1128/CVI.00131-10.
   PubMed Web of Science ®Google Scholar
• Patton K, Aslam S, Shambaugh C, Lin R, Heeke D, Frantz C, Zuo F, Esser MT, Paliard X, Lambert SL. Enhanced immunogenicity of a respiratory syncytial virus (RSV) F subunit vaccine formulated with the adjuvant GLA-SE in cynomolgus macaques. Vaccine. 2015;33:4472–78. doi:10.1016/j.vaccine.2015.07.025.
   PubMed Web of Science ®Google Scholar
• Pavot V, Rochereau N, Genin C, Verrier B, Paul S. New insights in mucosal vaccine development. Vaccine. 2012;30:142–54. doi:10.1016/j.vaccine.2011.11.003.
   PubMed Web of Science ®Google Scholar
• Ellner JJ, Hirsch CS, Whalen CC. Correlates of protective immunity to Mycobacterium tuberculosis in humans. Clin Infect Dis. 2000;30(Suppl 3):S279–82. doi:10.1086/313874.
   PubMed Web of Science ®Google Scholar
• Cunningham AL, Levin MJ. Herpes zoster vaccines. J Infect Dis. 2018;218:S127–S33. doi:10.1093/infdis/jiy382.
   PubMed Web of Science ®Google Scholar
• Ferreira MU, da Silva Nunes M, Wunderlich G. Antigenic diversity and immune evasion by malaria parasites. Clin Diagn Lab Immunol. 2004;11:987–95. doi:10.1128/CDLI.11.6.987-995.2004.
   PubMedGoogle Scholar
• Mustafaev MI, Yucel F, Ozturk S, Cirakoglu B, Bermek E. Cu(2+)-mediated complex formation between polyacrylic acid (PAA) and bovine serum albumin. J Immunol Methods. 1996;197:31–37. doi:10.1016/0022-1759(96)00107-X.
   PubMed Web of Science ®Google Scholar
• Andrianov AK, Marin A, Fuerst TR. Molecular-level interactions of polyphosphazene immunoadjuvants and their potential role in antigen presentation and cell stimulation. Biomacromolecules. 2016;17:3732–42. doi:10.1021/acs.biomac.6b01251.
   PubMed Web of Science ®Google Scholar